Identifying responders to acid suppression in dyspepsia using a random starting day trial

Functional dyspepsia is a heterogeneous condition and a uniform response to drug treatment is not likely. This may be the reason for the general failure of acid suppression in clinical trials in these patients. It may be more rewarding to identify true responders to drug treatment by a single subject trial.

[1]  P. Bytzer,et al.  H2 receptor antagonists and prokinetics in dyspepsia: a critical review , 2002, Gut.

[2]  J. Hansen,et al.  Value of the unaided clinical diagnosis in dyspeptic patients in primary care , 2001, American Journal of Gastroenterology.

[3]  M. Camilleri,et al.  Functional gastroduodenal disorders , 1999, Gut.

[4]  Talley,et al.  Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies) , 1998, Alimentary pharmacology & therapeutics.

[5]  I. Wiklund,et al.  Does endoscopy have a positive impact on quality of life in dyspepsia? , 1998, Gastrointestinal endoscopy.

[6]  M. Osnes,et al.  Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. , 1997, Scandinavian journal of gastroenterology.

[7]  G. Barbara,et al.  Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. , 1996, Gastroenterology.

[8]  P. Farup,et al.  Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine? , 1995, Scandinavian journal of gastroenterology.

[9]  M. Fennerty Empirical H2 blocker therapy or prompt endoscopy in the management of dyspepsia. , 1995, Gastrointestinal endoscopy.

[10]  Ø. Hovde,et al.  Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. , 1995, Scandinavian journal of gastroenterology.

[11]  L. Melton,et al.  Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. , 1992, American journal of epidemiology.

[12]  S. Larsen,et al.  Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. , 1991, Scandinavian journal of gastroenterology.

[13]  O. Flaten,et al.  The multi-crossover model for classifying patients as responders to a given treatment. , 1991, Scandinavian journal of gastroenterology.

[14]  O. B. Schaffalitzky de Muckadell,et al.  Efficacy and outcome of an open access endoscopy service. , 1991, Danish medical bulletin.

[15]  P. Knipschild,et al.  Looking for gall bladder disease in the patient's iris. , 1988, BMJ.

[16]  T. Halvorsen,et al.  Cimetidine responders in non-ulcer dyspepsia. , 1988, Scandinavian journal of gastroenterology.

[17]  R. Torp,et al.  Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern. , 1999, Scandinavian journal of gastroenterology.

[18]  O. B. Schaffalitzky de Muckadell,et al.  Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. , 1998, Scandinavian journal of gastroenterology.

[19]  H. Petersen,et al.  Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. , 1992, Scandinavian journal of gastroenterology.

[20]  L. Sandvik,et al.  The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. , 1985, Scandinavian journal of gastroenterology.